← FDA Drug Approvals (Drugs@FDA)
LAMOTRIGINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2016-06-17
Drug application
- FDA Application #
ANDA206382- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LAMOTRIGINE
- Generic name
- LAMOTRIGINE
- Active ingredients
- LAMOTRIGINE
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- SCIEGEN PHARMS
- Manufacturer
- Dr. Reddys Laboratories Inc.
- First approval
- 2016-06-17
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown